Н. А. Никитенко - Researcher Profile

Publications

2 shown

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

Denis Y. Logunov , Inna V. Dolzhikova , Olga V. Zubkova +29 more

2020 The Lancet 1109 citations

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Denis Y. Logunov , Inna V. Dolzhikova , Dmitry V. Shcheblyakov +28 more

A heterologous recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac (Sputnik V), showed a good safety profile and induced strong humoral and cellular immune responses in pa...

2021 The Lancet 1799 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 2,908
Institution: Ministry of Health of the Russian Federation

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-5829-744X

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.